Stock Screener - US Stocks, Forex and ETFs Please enable JavaScript to view this page content properly  
     
   MACD(12,26,9) Above Zero     
Criteria:
MACD(12,26,9) Above Zero
  Back to MACD Stock Screener
           
   Symbol   Name   Industry   Sector   Exchange  Cap, mln  Last  Change  Change, %  Volume
 A   Agilent Technologies  Medical Laboratories & Research Healthcare NYSE 25,840  78.99  -3.01 -3.7 1,395,751
 AAAU   Perth Mint Physical Gold ETF  Exchange Traded Fund Financial NYSE 1  13.117  0.04 0.3 10,529
 AABA   Altaba Inc  Asset Management Financial NASDAQ 41,690  72.01  -1.72 -2.3 7,680,441
 AADR   Advisorshares Dorsey Wright ADR  Exchange Traded Fund Financial NYSE 107  45.125  -1.03 -2.2 7,824
 AAMC   Altisource Asset  Asset Management Financial NYSE 59  34.50  0.15 0.4 424
 AAME   Atlantic Amer Cp  Life & Health Insurance Financial NASDAQ 59  2.65  -0.18 -6.4 101
 AAON   Aaon Inc  General Building Materials Industrial Goods NASDAQ 2,180  42.38  -1.90 -4.3 192,011
 AAP   Advance Auto Parts Inc  Auto Parts Stores Services NYSE 10,880  164.84  -4.23 -2.5 930,345
 AAPL   Apple Inc  Electronic Equipment Consumer Goods NASDAQ 859,030  191.05  -4.04 -2.1 41,952,030
 AAT   American Assets Trust  REIT - Retail Financial NYSE 2,140  45.11  -0.62 -1.4 268,225
Please sign up for viewing the full list of stocks.


Education MACD - Technical Analysis from A to Z
The MACD (Moving Average Convergence/Divergence) is a trend following momentum indicator that shows the relationship between two moving averages of prices. The MACD is the difference between a 26-day and 12-day exponential moving average. A 9-day exponential moving average, called the "signal" line is plotted on top of the MACD to show buy/sell opportunities. The MACD proves most effective in wide-swinging trading markets. There are three popular ways to use the MACD: crossovers, overbought/oversold conditions, and divergences. Learn more




Disclaimer - Privacy Policy - Cookie Use Policy - FAQ - Contact Us
Copyright ©2008-2019 MarketInOut.com. All rights reserved.
Best viewed in